Saudi Arabia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

Saudi Arabia’s infection control market is evaluated at US$141.204 million for the year 2020 and is projected to grow at a CAGR of 10.13% to reach a market size of US$277.436 million by the year 2027. With the increasing prevalence of chronic diseases and the highest rate of road accidents in the world, Saudi Arabia’s infection control market is projected to grow significantly in the forecast period. The market is estimated to continue to grow in the forecast period with the evolving healthcare landscape of the country. The growing health privatization with the intent to reduce dependence on the public sector is providing an opportunity for the market to increase at a rapid pace over the next five years.

The significant contribution of the healthcare sector to the national GDP is proving to contribute to the growth of the healthcare industry, further creating strong market growth prospects during the forecast period. The growing number of hospital beds in all the hospitals in the country is further projected to drive market growth in the forecast period and the upcoming years. The growth of the pharmaceutical industry in the Kingdom of Saudi Arabia coupled with the growing domestic manufacturing base is estimated to augment the market growth in the upcoming years.  

Growths Factor:

Growing healthcare privatization is driving the market demand in the forecast period and the upcoming years.

At present, public spending is still dominating in the country. However, significant efforts are being made in the expansion of privatization of government services in the healthcare sector as well, which will drive the market demand in the forecast period and the upcoming years. The Saudi government is promoting privatization in the country to reduce the country's reliance on the public sector.  The privatization of all the public hospitals in the country is projected to fulfil the objectives of the government’s National Transformation Program (NTP) 2020. The objectives include the expansion of the role of the private sector, increasing the number of licensed medical facilities, and doubling the number of primary care centres per capita visits from two to four; among other objectives. Such initiatives will further surge the market growth in the forecast period and the upcoming years.

The growing pharmaceutical sector, with encouraging domestic manufacturing of pharma products, is providing an opportunity for the market to grow in the upcoming years.

Significant initiatives for the domestic manufacturing of pharmaceutical products are poised to augment the market demand in the upcoming years. Also, as per the government plan, the local manufacturing base of pharmaceuticals will promote technology transfer, conduct clinical trials in Saudi Arabia, and train the Saudi labour force. The 2030 Vision and National transformation program are set to develop five industrial sectors which include the pharma and biotech industry as well. The following opportunities are identified for the growth of the pharma industry in the KSA: biologics and biosimilars, vaccine formulation, sterile injectables, solid oral dosage, and API, among others.

Recent development and expansions

Both SARS-CoV2 and MERS-CoV are lethal pathogens that can infect the Saudi population and wreak havoc on the Saudi healthcare system, particularly in the event of a combined outbreak. Raising public awareness of the gravity of the current situation will lead to better practice of social distancing and the maintenance of good hygiene. Notifying the country's healthcare authority to take timely measures to control infections from both of these pathogens will not only help to preserve the country's resources but will also lead to improvements in disease management and protocol within the hospital setting.

Allocation of healthcare resources is taking place toward accelerating the development of a MERS vaccine and conducting more research in areas involving the pathogenesis and demographics of COVID-19 and MERS could potentially open doors to further studies and aid in improving prevention and treatment measures. res and therapy

COVID-19 impact on Saudi Arabia Infection Control Market

According to the National Library of Medicine, King Saud Medical City (KSMC) is a quaternary care centre located in the heart of Riyadh, Saudi Arabia (KSA), and is one of the most important Ministry of Health (MoH) facilities in the central area for the treatment of patients with the COVID-19. To address the pandemic, a comprehensive surge plan was quickly launched in mid-March 2020, and it was phased in. A key component of the surge plan was to strengthen the capacity of the infection prevention and control department (IPCD). To address the various facets of the pandemic containment procedures, task force infection control teams were established.

According to science direct, it was discovered that all health care workers (HCWs) in Saudi hospitals had excellent knowledge of risk management plans and pandemic sub-plans of infection control and prevention policies, procedures, and principles, assisting Saudi health authorities in effectively mitigating COVID-19. Such initiatives by the government surged the market growth of Saudi Arabia’s infection control market during the pandemic.

Saudi Arabia Infection Control Market Scope:

Market Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low-temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical